ATC drug classification of Canadian drugs

M MUSCULO-SKELETAL SYSTEM

M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS

M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS

M01AB Acetic acid derivatives and related substances
M01AB01 - indometacin (Wiki, WHO)
M01AB02 - sulindac (Wiki, WHO)
M01AB05 - diclofenac (Wiki, WHO)
M01AB08 - etodolac (Wiki, WHO)
M01AB15 - ketorolac (Wiki, WHO)
M01AB55 - diclofenac, combinations (Wiki, WHO)

M01AC Oxicams
M01AC01 - piroxicam (Wiki, WHO)
M01AC02 - tenoxicam (Wiki, WHO)
M01AC06 - meloxicam (Wiki, WHO)

M01AE Propionic acid derivatives
M01AE01 - ibuprofen (Wiki, WHO)
M01AE02 - naproxen (Wiki, WHO)
M01AE03 - ketoprofen (Wiki, WHO)
M01AE09 - flurbiprofen (Wiki, WHO)
M01AE11 - tiaprofenic acid (Wiki, WHO)
M01AE51 - ibuprofen, combinations (Wiki, WHO)
M01AE52 - naproxen and esomeprazole (Wiki, WHO)

M01AG Fenamates
M01AG01 - mefenamic acid (Wiki, WHO)

M01AH Coxibs
M01AH01 - celecoxib (Wiki, WHO)

M01AX Other antiinflammatory and antirheumatic agents, non-steroids
M01AX01 - nabumetone (Wiki, WHO)

M01B ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION

M01C SPECIFIC ANTIRHEUMATIC AGENTS

M01CB Gold preparations
M01CB01 - sodium aurothiomalate (Wiki, WHO)
M01CB03 - auranofin (Wiki, WHO)

M01CC Penicillamine and similar agents
M01CC01 - penicillamine (Wiki, WHO)

M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN

M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN

M02AA Antiinflammatory preparations, non-steroids for topical use
M02AA15 - diclofenac (Wiki, WHO)

M02AC Preparations with salicylic acid derivatives
M02AC - preparations with salicylic acid derivatives (Wiki, WHO)

M02AX Other topical products for joint and muscular pain
M02AX10 - various (Wiki, WHO)

M03 MUSCLE RELAXANTS

M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS

M03AB Choline derivatives
M03AB01 - suxamethonium (Wiki, WHO)

M03AC Other quaternary ammonium compounds
M03AC09 - rocuronium bromide (Wiki, WHO)
M03AC11 - cisatracurium (Wiki, WHO)

M03AX Other muscle relaxants, peripherally acting agents
M03AX01 - botulinum toxin (Wiki, WHO)

M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS

M03BA Carbamic acid esters
M03BA03 - methocarbamol (Wiki, WHO)
M03BA53 - methocarbamol, combinations excl psycholeptics (Wiki, WHO)

M03BB Oxazol, thiazine, and triazine derivatives
M03BB53 - chlorzoxazone, combinations excl psycholeptics (Wiki, WHO)

M03BC Ethers, chemically close to antihistamines
M03BC01 - orphenadrine (citrate) (Wiki, WHO)

M03BX Other centrally acting agents
M03BX01 - baclofen (Wiki, WHO)
M03BX02 - tizanidine (Wiki, WHO)
M03BX08 - cyclobenzaprine (Wiki, WHO)

M03C MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS

M03CA Dantrolene and derivatives
M03CA01 - dantrolene (Wiki, WHO)

M04 ANTIGOUT PREPARATIONS

M04A ANTIGOUT PREPARATIONS

M04AA Preparations inhibiting uric acid production
M04AA01 - allopurinol (Wiki, WHO)
M04AA03 - febuxostat (Wiki, WHO)

M04AB Preparations increasing uric acid excretion
M04AB02 - sulfinpyrazone (Wiki, WHO)

M04AC Preparations with no effect on uric acid metabolism
M04AC01 - colchicine (Wiki, WHO)

M05 DRUGS FOR TREATMENT OF BONE DISEASES

M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION

M05BA Bisphosphonates
M05BA01 - etidronic acid (Wiki, WHO)
M05BA02 - clodronic acid (Wiki, WHO)
M05BA03 - pamidronic acid (Wiki, WHO)
M05BA04 - alendronic acid (Wiki, WHO)
M05BA07 - risedronic acid (Wiki, WHO)
M05BA08 - zoledronic acid (Wiki, WHO)

M05BB Bisphosphonates, combinations
M05BB01 - etidronic acid and calcium, sequential (Wiki, WHO)
M05BB03 - alendronic acid and cholecalciferol (Wiki, WHO)

M05BX Other drugs affecting bone structure and mineralization
M05BX04 - denosumab (Wiki, WHO)

M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULOSKELETAL SYSTEM

M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULOSKELETAL SYSTEM

M09AB Enzymes
M09AB02 - collagenase clostridium histolyticum (Wiki, WHO)

M09AX Other drugs for disorders of the musculo-skeletal system
M09AX07 - nusinersen (Wiki, WHO)